Contribution of the regulatory gene lasR to the pathogenesis of Pseudomonas aeruginosa infection of burned mice

Journal of Burn Care and Rehabilitation

Volumn 20, Issue 1 I, 1999, Pages 42-49

  Rumbaugh, Kendra P ^a   Griswold, John A ^b   Hamood, Abdul N ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PROTEINASE; ELASTASE; PSEUDOMONAS EXOTOXIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MUTATION; BACTERIAL VIRULENCE; BURN; COLONY FORMING UNIT; INFECTION RISK; LETHALITY; MOUSE; NONHUMAN; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; QUANTITATIVE DIAGNOSIS; REGULATOR GENE; STRAIN DIFFERENCE;

EID: 0032902993     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-199901001-00008     Document Type: Article

References (33)

1. Wood RE. Pseudomonas: the compromised host. Hosp Pract 1976;11:91-100.
2. Pitcher-Wilmott RW, Levinsky RJ, Gordon I, Turner MW, Matthew DS. Pseudomonas and infection, allergy and cystic fibrosis. Arch Dis Child 1982;57:582-6.
3. Bodey G, Bolivar R, Fainstein V, Jadeja L. Infections caused by Pseudomonas aeruginosa, Rev Infect Dis 1983;5:279-313.
4. Cash HA, Straus DC, Bass JA. Pseudomonas aeruginosa exo-products as pulmonary virulence factors. Can J Microbiol 1983;29:448-56.
5. Woods DE, Iglewski BH. Toxins of Pseudomonas aeruginosa: new perspectives. Rev Infect Dis 1983;5:S715-22.
6. Homma JY. Role of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine. Jpn J Exp Med 1980;50:149-65.
7. Wretlind B, Pavlovskis OR. Pseudomonas aeruginosa proteases and their role in Pseudomonas infections. Rev Infect Dis 1983;5:S998-1004.
8. Iglewski BH, Sadoff JC, Bjorn MJ, Maxwell ES. Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyl transferase distinct from toxin A. Proc Natl Acad Sci U S A 1978;75:3211-5.
9. Berka RM, Gray GL, Vasil ML. Studies of phospholipase C (heat-labile hemolysin) in Pseudomonas aeruginosa. Infect Immun 1981;34:1071-4.
10. Peters JE, Park SJ, Darzins A, Freck LC, Saulnier JM, Wallach JM, et al. Further studies on Pseudomonas aeruginosa LasA: analysis of specificity. Mol Microbiol 1992;6:1155-62.
11. Morihara K, Homma JY. Pseudomonas proteases. In: Holder IA, editor. Bacterial enzymes and virulence. Boca Raton (FL): CRC Press, Inc; 1985. p. 41-9.
12. Schultz DR, Miller KD. Elastase of Pseudomonas aeruginosa: inactivation of complement components and complement-derived chemotactic and phagocytic factors. Infect Immun 1974;10:128-35.
13. Toder D, Gambello MJ, Iglewski BH. Pseudomonas aeruginosa LasA: a second elastase under the transcriptional control of LasR. Mol Microbiol 1991;5:2003-10.
14. Peters JE, Galloway DR. Purification and characterization of an active fragment of the LasA protein from Pseudomonas aeruginosa: enhancement of elastase activity. J Bacteriol 1990;172:2236-40.
15. Kessler E, Safrin M, Olsen J, Ohman DE. Secreted LasA of Pseudomonas aeruginosa is a staphylolytic protease. J Biol Chem 1993;268:7503-8.
16. Woods DE, Sokol PA, Bryan LE, Storey DG, Mattingly SJ, Vogel HJ, et al. In vivo regulation of virulence in Pseudomonas aeruginosa associated with genetic rearrangment. J Infect Dis 1991;163:143-9.
17. Ohman DE, Burns RP, Iglewski BH. Corneal infections in mice with toxin A and elastase mutants of Pseudomonas aeruginosa. J Infect Dis 1980;142:547-55.
18. Stieritz DD, Holder IA. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J Infect Dis 1975;131:688-91.
19. Stieritz DD, Holder IA. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: direct evidence of toxin production during pseudomonas infection of burned skin tissues. J Infect Dis 1977;136: 555-61.
20. Pavlovskis OR, Pollack M, Callahan LT, Iglewski BH. Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections. Infect Immun 1977;18:596-602.
21. Nicas TI, Iglewski BH. The contribution of exoproducts to virulence of Pseudomonas aeruginosa. Can J Microbiol 1985;31:387-92.
22. Pavlovskis OR, Wretlind B. Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection. Infect Immun 1979;24:181-7.
23. Gambello MJ, Iglewski BH. Cloning and characterization of the Pseudomonas aeruginosa lasR: a transcriptional activator of elastase expression. J Bacteriol 1991;173:3000-9.
24. Gambello MJ, Kaye S, Iglewski BH. LasR of Pseudomonas aeruginosa is a transcriptional activator of the alkaline protease gene (apr) and an enhancer of exotoxin A expression. Infect Immun 1993;61:1180-4.
25. Holloway B, Krishnapillai V, Morgan AF. Chromosomal genetics of Pseudomonas. Microbiol Rev 1979;43:73-102.
26. Hamood AN, Griswold JA, Duhan CM. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections. J Surg Res 1996;61:425-32.
27. Hamood AN, Griswold JA, Colmer J. Characterization of elastase-deficient clinical isolates of Pseudomonas aeruginosa. Infect Immun 1996;64:3154-60.
28. Meyer JM, Neely A, Stintzi A, Georges C, Holder IA. Pyoverdin is essential for virulence of Pseudomonas aeruginosa. Infect Immun 1996;64:518-23.
29. Neely AN, Nathan P, Highsmith RF. Plasma proteolytic activity following burns. J Trauma 1988;28:362-7.
30. Holder IA, Neely AN. The role of proteases in Pseudomonas infections in burns: a current hypothesis. Antibiot Chemother 1991;44:99-105.
31. Holder IA. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: effect of treatment with protease inhibitors. Rev Infect Dis 1983;5:S914-21.
32. Cicmanec JF, Holder IA. Growth of Pseudomonas aeruginosa in normal and burned skin extract: role of extracellular proteases. Infect Immun 1979;25:477-83.
33. Steel RG, Torrie JH. Principles and procedures of statistics. A biometrical approach. 2nd ed. New York: McGraw-Hill, Inc; 1980. p. 504-6.